Case Study of the Week

Is the current lung cancer a new primary or a recurrence of a prior epiglottis cancer?
Read More

RedPath in the News

RedPath Integrated Pathology, Inc. Acquired By ExonHit Therapeutics, S.A.
Read

RedPath Integrated Pathology, Inc. Announces Professional Services Agreement with Allegheny General Hospital
Read

More News

Events

More Events

About: News/Events

Biotech company doubles work force, plans to step up sales efforts

Pittsburgh Business Times
By Jennifer Curry

“Since raising $6.5 million in its first major funding round last October, Redpath Integrated Pathology, Inc. has doubled its work force and expanded its management team as it prepares to ramp up its sales efforts. This North Side-based biotech company, which provides specialized cancer diagnostic tools for pathologists, oncologists and clinicians, has grown to 22 employees and has added three new seasoned executives to help play an integral role in the company’s next stage of development: seeking growth through new partnerships, new clients and greater use of its product by existing clients.”

Read More